Cargando…
The partial µ-opioid agonist buprenorphine in autism spectrum disorder: a case report
BACKGROUND: There are currently no approved medications for impaired social cognition and function, core symptoms of autism spectrum disorder. We describe marked improvement of these symptoms with long-term low-dose administration of the partial µ-opioid agonist buprenorphine. We discuss these obser...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011926/ https://www.ncbi.nlm.nih.gov/pubmed/35422015 http://dx.doi.org/10.1186/s13256-022-03384-w |